Neglected Diseases: Who Should Pay for Vaccine Research?

Oct. 20 (Bloomberg) -- Christopher Egerton-Warburton, fund manager at Global Health Investment Fund, and Martin McKee of London School of Hygiene and Tropical Diseases discuss the lack of preparation and research into vaccines for Ebola and similar tropical diseases. They speak on “The Pulse.”

Fidelity's Tillinghast Bemoans Shrinking Pool of Stocks
11:49 - Joel Tillinghast, fund manager at Fidelity Investments, discusses the shrinking number of publicly traded firms. He speaks with Bloomberg's Erik Schatzker. (Source: Bloomberg)
  • Full Show: Bloomberg Daybreak: Americas (09/11)
  • Full Show: Bloomberg Daybreak: Americas (09/01)
  • Full Show: Bloomberg Daybreak: Americas (08/31)